• Sun. May 12th, 2024
    • '
    Aflibercept 8 mg veryfirst to accomplish continual vision gains with more than 70% of clients extended to periods inbetween 16 and 24 weeks in damp age-related macular degeneration at 2 years
    Tamil

    Aflibercept 8 mg veryfirst to accomplish continual vision gains with more than 70% of clients extended to periods inbetween 16 and 24 weeks in damp age-related macular degeneration at 2 years

    author
    0 minutes, 13 seconds Read

    10

    August

    2023

    |

    12: 59 PM

    Europe/Amsterdam

    Not designated for U.S. and UK Media – Two-year topline results from the critical researchstudy PULSAR:

    Summary

    Results from PULSAR show long term effectiveness of

    Read More.

    Similar Posts